Benign hepatic tumors include a broad spectrum of regenerative and true neoplastic processes. Because of advances in imaging studies such as computed tomography (CT) and magnetic resonance imaging (MRI) as well as progress in immunohistochemistry, accurate diagnosis can now be made in a large percentage of patients without surgical laparotomy or resection. This article will focus on the pathogenesis, diagnosis, and management of focal benign lesions ofthe liver. Many ofthese tumors present with typical features in various imaging studies. On occasions, biopsies are required and/or surgical removal is needed. The most common benign hepatic tumors include cavemous hemangioma, focal nodular hyperplasia, hepatic adenoma, and nodular regenerative hyperplasia. In the majority of cases of benign hepatic tumors, patients are asymptomatic, and no treatment is indicated. The main indication for treatment is the presence of significant cIinical symptoms or suspicion of malignancy or fear of malignant transformation.
B
enign hepatic tumors are increasingly reported with the widespread use of sensitive imaging studies and occasionally present significant diagnostic and therapeutic challenges. They usually occur in asymptomatic patients with or without underlying liver disease. Using simple imaging techniques such as ultrasound (US), benign hepatic tumors can be categorized as solitary or multiple and as solid or cystic as shown in Table 1 .1-3 In general, a single imaging study is insufficient for a definitive diagnosis, and further studies may be necessary. Most benign hepatic tumors follow a fairly indolent clinical course. However, some ofthem are associated with serious complications. Thus, the understanding of clinical, radiologic, and pathologic characteristics of each tumor is important for accurate diagnosis and appropriate treatrnent of these tumors. This article will review several benign hepatic tumors that are commonly encountered in adults. We will categorize them as solid or cystic tumors and describe key differential diagnostic criteria for each tumor. We will also propose a stepwise approach for diagnosis and 
Imaging
The majority of hemangiomas can be diagnosed accurately by imaging studies alone since hemangiomas usually have characteristic imaging features. They may be isolated or multiple as in up to 50% of patients.9 On US, hemangioma typically appears as a well-defined, lobulated, homogeneous hyperechoic mass, but it may also have hypoechoic portion due to hemorrhage, fibrosis, or calcification. The accuracy of US is reported to be 70% to 80%.28 Contrast-enhanced harmonic US imaging demonstrates peripheral nodular enhancement in the portal phase and the absence of intratumoral vesse\s in the arterial phase, which is often present in hepatocellular carcinoma (HCC). 11.12 Hemangiomas are ftequently missed on standard CT, but theycan often be diagnosed by multiphasic CT.In early enhanced images, they show peripheral nodular or globular enhancement. As time goes by, contrast enhancement progresses centripetally. In delayed enhanced images, they appear as uniformly enhanced tumors.13The best, although most expensive, imaging study for hemangiomas is MRI with sensitivity and specificity between 85% and 95%. Bright signal intensity on T2-weighted images and similar enhancement pattem to enhanced CT are very specific and effective for accurate diagnosis (Fig. 2 ).14.15 Single photon emission computed tomography (SPECT) with technetium-Iabeled red blood cell has similar sensitivity and specificity to MRI for hemangioma only if the tumor is larger than 3 cm and close to the surface. 4 .5Because ofthese limitations, SPECT should be used as a supplementary test.
However, there are also atypical findings of hemangiomas such as cystic hemangiomas or small hemangiomas with immediate homogeneous enhancement.16.17 In these cases, pathologic conformation via needle biopsy is required, although it is still debatable whether needle biopsy can be safely performed in hypervascular tumors such as hemangioma. One 402 retrospective study of percutaneous biopsy of 38 patients with suspected hemangiomas using 20-gauge needles reported that it is safe and effective for establishing the diagnosis of hemangiomas. In that study, hemangiomas range in size from 1 cm to 13.5 cm, with a mean of 3 cm.4
Management
Treatment is not indicated for asymptomatic patients with hemangiomas that are less than 5 cm after the diagnosis is established and stability can be demonstrated on at least one follow-up study at 6-month interval. 4 Asymptomatic patients with giant hemangiomas may need to be monitored more closely. Indications for treatment include severe symptoms, complications, and inability to exclude malignancy.18 Treatment includes surgical enucleation, resection, transarterial catheter chemoembolization, hepatic irradiation, and transplantation.5.19 Surgical resection and enucleation are applicable for single hemangioma. Transplantation may be necessary in large umesectable lesions, multiple lesions, or those involving the hepatic hilum.
Summary
Hemangiomas are the most common benign tumors of the liver. They are often asymptomatic and are found incidentally on imaging studies. Complications are uncommonoDiagnosisis usuallymadeby characteristicradiographic features,and MRI is the most sensitiveand specificdiagnostic modality. Treatment depends on the patient's clinical presentation.
Focal Nodular Hyperplasia Pathogenesis and Pathology
Focal nodular hyperplasia (FNH) is the second most common benign solid tumor of the liver and makes up approximately 8% of ali primary hepatic tumors.4.9The pathogenesisofFNH is not well understood.In the past, FNH wasthoughtto be eithera hamartomaor a neoplasmthat forms in response to ischemia. However, more recently, it is considereda nonneoplastic,hyperplasticresponseto a congenital vascular malformation.7Histologically,FNH is defined as a tumor consisting of benign-appearinghepatocytes occurring in the liver that is normal or nearly normal. 20 FNH is encountered in as many as 3% of general population, predominantly in childbearing-agedwomen with a femaleto-male ratio of 6 to 8:1.5 Oral contraceptive use may be associated with FNH, but its association is not clear. Most investigatorsagree that the use of oral contraceptivedoes not inducethe formationof FNH, but it acts onlyto acceleratethe growthof already formedtumors.21FNH most often presents as a solitary,less than 5-cm nodule near the hepatic surface, although large masses up to 15 cm in diameter have been reported: 4 On gross pathology,it is usually a well-circumscribed, globular, lobulated but not encapsulated tumor.21The characteristichistologic featuresof FNH include a dense, central stellate scar and septa that radiate from the central scar. The septa divide the tumor into severalnodules. Microscopically, this scar is composed of bile ductules, cholangiolar metastasis, is critical to ensure appropriate treatment and follow-up.
Imaging
As in the case with histologic study, the central fibrous scar is the most characteristic finding in imaging studies. US is often the initial imaging modality that indicates a focal hepatic lesion, but FNH is not well demonstrated by simple sonographic technique. There is only a subtle difference of echogenicity between FNH and the surrounding normal liver. FNH may be slightly hypoechoic, isoechoic, or slightly hyperechoic. Some of them may show a hypoechoic halo surrounding the tumor,z°Color and power Doppler US may be helpful for detecting the vascularity in suspected FNH. In addition, use of US contrast media has been reported. After injection of contrast media (Levovist; Schering AG, Berlin, Germany), FNH demonstrates strong homogeneous activity similar to adjacent hepatic parenchyma. The mechanism of its uptake is thought to be related to Kupffer cell activity. This can be a differential point ITomother malignant hepatic tumors that typically demonstrate no uptake as focal defects.24 Despites 404 FIGURE3. FNH.A, UnenhancedTl-weighted image demonstrates a smoothly marginated isointense tumor with a hyperintense portion. B, Fat saturation T2-weighted image reveals slightly hyperintense tumor with a central scar and its intensely bright signal. C, Enhanced Tl-weighted image shows a homogeneous enhanced tumor with hypointense central scar.
these possibilities, US is currently not considered the modality of choice for characterization of FNH.
On multiphasic CT and enhanced MRI, typical features ofFNH are very characteristic (Fig. 3) is usually homogeneous and iso-attenuating to the nonnal liver before contrast injection. At late arterial phase, FNH typically presents with a bright homogeneous enhancement and a hypodense central scar. The radiating hypodense fibrous bands or septa, arising from the scar, are infrequent but quite characteristic. At portal phase, FNH retums to isoattenuating to the nonnalliver and may be difficult to detect. Delayed phase often shows hyperattenuation ofthe central scar and septa due to the late opacification of the fibrotic components. Dilated feeding arteries penetrating central scar and draining veins running at the surface of the tumor may be recognized in large FNH.13 Because early hyperattenuation of the tumor is the most reliable sign, multidetector computed tomography (MDCT), which allows the rapid scanning of the entire liver at the late arterial phase, can facilitate the characterization of FNH. \3 On MRI, FNH is slightly hypointense on Tl-weighted images and slight1yhyperintense on T2-weighted images. FNH may also be nearly isointense on both Tl-and T2-weighted images. Unlike hepatic adenoma, FNH rarely has higher signal intensity than the liver on Tl-weighted images. 25 The central scar is usually hyperintense on T2-weighted images. On dynamic contrast-enhanced MR images, FNH shows similar enhancement pattem to multiphasic CT (Fig. 3) . Superparamagnetic iron oxide (SPIO) is an MR contrast agent that undergoes phagocytosis by the RES system (Kupffer cell). On SPIO-enhanced T2-weighted images, FNH is hypointense, whereas the central scar is more conspicuous.9.21 On MR images with hepatobiliary contrast agents, FNH appears hyperintense in relation to the nonnal liver, and the central scar remains hypointense.8 In addition to these typical imaging features, atypical CT and MRI findings also OCCUf. These include multiple lesions, heterogeneity or fat component within the tumor, nonvisualization of the central scar, and pseudo-capsular enhancement. 26 On hepatic scintigraphy with 99m Tc-sulfur-colloid, FNH shows nonnal (30%), increased (30%), and decreased (30%) colloid uptake compared with the nonnalliver. In 10% of cases, uptake is intense, and this is a very specific finding for FNH.21 Hepatic adenoma usually has decreased uptake. 27 The amount of uptake depends on the size and number of Kupffer and fibrous cells. Radiologically, FNH is sometimes mistaken as fibrolamellar HCC, but the fibrous scar of fibrolamellar HCC is usually large and eccentric with broad fibrous bands and ca1cifications.8If all of the imaging studies fail to establish a finn diagnosis, histologic examination is warranted. By combining different imaging modalities, especially by using MRI, a precise diagnosis of FNH can be achieved in 70% to 90% of cases in centers with expertise in the appropriate imaging techniques.8
Management
In asymptomaticpatientswith FNH, treatmentgenerally includes clinical follow-up to observe for the development of symptoms and radiologic follow-up with US to detect enlarging tumors.z9Most of resected cases are due to the undetenninednature of the tumor,the presence of symptoms, or suspicion of metastasisin patients previouslyoperated for 
Snmmary
FNH is the second most common benign tumor of the liver, next to hemangioma. Patients are rarely symptomatic. Multiphasic CT and enhanced MRI are the most useful diagnostic modalities. Definitive diagnosis may require histologic examination in selected cases. Treatrnent includes conservative clinical follow-up in asymptomatic patients. Surgical resection is indicated for those with significant symptoms or in whom malignancy cannot be excluded by radiologic and histologic studies.
Hepatic Adenoma

Pathogenesis and Pathology
Hepatic adenoma (HA) is arare hepatic tumor that is pathologically characterized by the benign proliferation of hepatocytes. As seen with FNH, HA also occurs predominant1y in young women with a female-to-male ratio of 4: 1. 5 The pathogenesis of HA remains disputed, but the strong association with oral contraceptive use has been documented. HA was extremely rare before the introduction of oral contraceptives in the 1960s. Since 1960s, the incidence has great1y increased, and HA occurs more frequent1y in patients with a history of long-tenn and high-dose estrogen use. 30 Withdrawal of oral contraceptives is reported to induce the regression of the tumor, although this may take several months. 22 In addition to oral contraceptives, anabolic androgen-containing steroid medications also may increase the incidence, number, and size of HA. Another risk group for HA includes patients with glycogen storage disease. The prevalence is 50% in patients with Type I glycogen storage disease (von Gierke) and 25% with Type III disease. 4 In these patients, adenomas are also more likely to be multiple and to undergo malignant transfonnation, although the latter is still rare. 31 Macroscopically, HA is usually solitary (70%-80%), wellcircumscribed, round, unencapsulated, but it often fonns pseudo-capsules by compressing adjacent hepatic tissue. They have yellow-tan color with diameter ranging from 5 to 15 cm, and up to 30 cm on rare occasions.4 Grossly, intratumoral fat, necrosis, hemorrhage, or large subcapsular vessels are commonly observed. Microscopically, HA includes large plates of cells that resemble nonnal hepatocytes and are separated by dilated sinusoids. These sinusoids are perfused by feeding arteries, which contribute to the hypervascularity of HA. 
Imaging
On US, hepatic adenomas have variable and nonspecific appearances depending on the character of the tumor. Hypoechoic, hyperechoic, and mixed-echoic patterns represent simple adenoma, adenoma with fatty metamorphosis, hemorrhage, and necrosis, respectively.32 Color Doppler US sometimes demonstrates peripheral peritumoral and intratumoral vessels with a flat continuous or uncommonly, triphasic waveform. These findings are absent in FNH, so it can be used to differentiate between these 2 types of tumors.30 US findings with contrast enhancement using Levovist may also be helpful. In the hepatic phase, 5 minutes following contrast injection, the tumor shows relatively low uptake in comparison with the surrounding liver. Other benign tumors that have strong Kupffer cell activity such as FNH and some hemangiomas demonstrate strong homogeneous activity similar to adjacent hepatic parenchyma, while malignant tumors such as HCC and metastasis demonstrate no uptake. 24.33 On multiphasic CT and MRI, HA may show more specific findings. Unlike FNH, HA is frequent\y heterogeneous due to intratumoral hemorrhage, necrosis, and fat components on CT. HA containing none of these components is nearly iso-attenuating to normalliver on unenhanced phase as well as portal-venous and delayed phases. HA shows early enhancement because of their rich arterial supply. Peripheral enhancement with centripetally progression is often detected, reflecting the presence of the large subcapsular feeding vessels. 26 MRI findings can also be very characteristic. On TIweighted images, adenomas have been described variously as hyperintense, isointense, or hypointense due to the presence of hemorrhage, necrosis, or fat components. However, 35% to 77% of cases are described as hyperintense. On T2-weighted images, 47% to 74% of adenomas are also predominant\y hyperintense.30 On dynamic contrast-enhanced MR images, HA demonstrates early arterial enhancement. SPIO-enhanced MR is useful to distinguish adenomas from HCC. In contrast to HA, which typically shows signalloss on T2-weighted images, malignant hepatic tumors generally lack Kupffer cells 406 and show no signal IOSS.34As discussed earlier, hepatic scintigraphy with 99mTc-sulfur-colloid demonstrates HA with absent or decreased uptake, reflecting decreased number or function of Kupffer cells.
Management
Because ofthe risk of spontaneous rupture and malignant transformation, HA must be identified and treated prompt\y. After the diagnosis of HA, the most common recommended treatrnent is a surgical resection due to the above complications.29.30 However, especially in small «5 em) HA, discontinuation of estrogen and follow-up with US can also be considered. 35 The treatrnent options include surgical enucleation, resection, transplantation, and hepatic arterial embolization, which is also an effective option for the treatrnent of HA with acute hemorrhage.30 Liver transplantation is required for patients with diffuse or multifocal adenomas. Laparoscopic surgery offers an alternative modality for small HA with good surgical outcomes according to one case series with 17 patients of HA.28
Summary
HA is arare benign tumor; however, it is important to recognize this tumor and to differentiate it from other hepatic tumors because of the risk of hemorrhage and malignant transformation. HA is usually detected with US, but it has no specific features on US. Color Doppler US, multiphasic CT, and MR can offer better characterization of HA. Criteria that guide treatrnent include the number and size ofthe lesions, the presence of symptoms, and the surgical risk incurred by patients.
Other Types of Hepatic Adenoma
Hepatic Adenomatosis
Hepatic adenomatosis is defined as more than 10 adenomas, and it is considered a distinct disease entity due to different clinical features.36 It has been reported in the absence of oral contraceptive use or glycogen storage disease with M:F ratio of I: 1. Patients often present with clinical symptoms such as abdominal pain, hepatomegaly, and impaired liver function. Adenomatosis has higher tendency toward rupture, hemorrhage, and malignant transformation, leading to a poorer prognosis. 36 The imaging and histologic features are similar to adenomas. Diagnosis is usually made by exclusion of other hepatic tumors, since multifocal HCC or metastasis is much more common in the presence of multiple solid hepatic lesions. Close follow-up is warranted and liver transplantation is sometimes necessary.37
Intrahepatic Bife Duct Adenoma
Bile duct adenoma is a benign and asymptomatic mass that is typically discovered incidentally at imaging studies, surgery, or at autopsy. I It is usually a well-circumscribed, subcapsular mass with a diameter ofless than I em and composed of bile ductules, inflammatory cell, and fibrosis. Radiologic imaging findings are nonspecific. Histologic analysis is the key in differentiating intrahepatic bile duct adenoma from other hepatic malignancy such as cholangiocarcinoma or metastasis. Treatrnent is usually not required.
Nodular Regenerative
Hyperplasia Pathogenesis and Pathology Nodular regenerative hyperplasia (NRH) is a benign proliferative lesion, which has been referred to by many names in the literature including nodular transformation, noncirrhotic nodulation, and partial nodular transformation. It is a distinct disease entity characterized by diffuse involvement ofthe liver with nodules composed of hyperplastic hepatocytes, and it should not be confused with the regenerative nodules of cirrhosis or FNH.9 Macroscopically, NRH is characterized by multiple bulging regenerative nodules in clusters with ranging sizes ITom0.1 to 4 cm. This gross finding may not be different ITom micronodular cirrhosis.5 However, microscopic features are very characteristic and readily distinguishable ITom cirrhosis. Histologic examination reveals the regeneration of hepatocytes with multinucleated hepatocytes and thickened regenerating hepatocytes with centrilobular atrophy. These regenerating nodules also compress the central veins curvilinearly, and there is a lack of fibrotic reactions. On the other hand, NRH and HA share similar benign process and histologic eIements and are difficult to be distinguished ITom each other based on a single-needle biopsy. Multiple biopsies are often helpful as NRH is a diffuse or multinodular process, whereas HA is a solitary process in which the remainder ofthe liver is normal. 22 The pathogenesis ofNRH is not well known. One ofthe proposed theories hypothesizes that a primary vascular process leads to obliteration of portal vein, which in tum induces ischemia, atrophy of hepatocytes in the central zone, and the proliferation of hepatocytes.38 The other theory proposes that a preneoplastic process leads to NRH due to the reported high prevalence of hepatocyte dysplasia (200/0-42%) and HCC formed in livers of patients with NRH.39 According to two large case series, the prevalence of NRH was reported to be 2.1% and 2.6%.4 NRH mostIy affects patients older than 50 years of age, and the gender distribution of NRH is variable.
Wide spectrum of systemic diseases and drugs are also associated with NRH such as myeloproliferative disorders, Iymphoproliferative disorders, chronic vascular disorders, rheumatologic and collagen vascular diseases (rheumatoid arthritis, Felty's syndrome, polyarteritis nodosa, amyloidosis, and primary biliary cirrhosis), solid organ transplantation (renal and liver transplantation), and use of steroids or chemotherapeutic agents. 22 
Clinical Presentation
Clinically, NRH usually cause no symptoms and are discovered incidentally during imaging studies or surgery. Some patients present mainly with symptoms of portal hypertension such as hepatomegaly, splenomegaly, ascites, or esophageal varices due to the compression of the main portal vein at the hepatic hilum. Other cholestatic symptoms can also occur.40Mild and nonspecific eIevated liver function tests may be seen. Rarely, hepatic failure, rupture of the liver, or malignant transformation can occur. 
Imaging
Imaging findings are not specific, and histologic examination is often warranted. In most cases, US shows normal hepatic parenchyma. In a few cases, well-delineated hypoechoic or isoechoic nodules can be depicted. Hyperechoic nodules have been reported in very rare cases. 41 On enhanced CT, NRH shows normal findings or hypoattenuating nodules. Hyperattenuating portion of nodule represents hemorrhage or arterioportal shunting.22,41There are only a few reports on the MR findings. Lesions are described as hyperintense on Tlweighted images and iso-or hypointense to normal liver on T2-weighted images.42.43
Management
Accurate diagnosis should be confirmed with histologic examination prior to treatment. In highly suspicious cases, open biopsy is indicated to obtain adequate sample of hepatic tissue since percutaneous needle biopsies may give falsely normal results.4 Management depends on the cIinical symptoms. In asymptomatic patients, no treatment is recommended except for periodic follow-up to monitor for development of HCC, although this is very rare. In patients with complications ofportal hypertension, appropriate management including drug therapy, endoscopic therapy, or portocaval shunt is necessary. 4 Rarely, patients may progress to liver failure and finally require liver transplantation.5
Summary
NRH is another benign hepatic tumor that is often detected as incidental findings. The diagnosis ofNRH usually requires clinical, radiologic, and histologic examinations. Accurate diagnosis is the key, and treatment is indicated based on the patient's cIinical presentations.
Macroregenerative Nodule
Pathogenesis and Pathology Macroregenerative nodule (MRN) was previously cIassified as adenomatous hyperplasia or high-grade dysplastic nodule (> I cm).25 MRN occurs on the background of the cirrhotic liver, acute massive or submassive necrotic liver. Nowadays, MRNs are more ITequentIy detected in liver explants after orthotropic liver transplantation. 44 Clinical importance of MRN is its malignant transformation to HCC, although it is not cIear how what percentage of MRN will progress to malignancy. The reported prevalence of MRN varies between 14.2% and 25% on autopsy series. 44 In acute massive or submassive necrosis, remaining hepatic parenchyma shows compensatory lobular hyperplasia after parenchymal loss. In cirrhotic liver, the hyperplastic reactions occur as a result of even a larger amount of cellloss. Regenerating islets of viable cells are formed between destructed areas, and these islets make up the nodular structures. 7 Macroscopically, MRN has a greener or paler color compared with the surrounding cirrhotic liver. As compared with HCC, MRN has lower proliferation indices, which is no greater than three-cell thickness. 23 
Other Solid Tumors
Mesenchymal Hamartoma
Mesenchymal hamartoma of the liver is an uncommon benign lesion composed ofbile ducts, immature mesenchymal cells, and hepatocytes.49 Most of them are diagnosed during childhood, although a few cases have been reported in adults. 50 The clinical presentation is nonspecific, and imaging findings reveal solid or multicystic lesions.51 Although hamartoma can be diagnosed by percutaneous biopsy, diagnosis is usually established after surgical excision.
Focal Fatty Change
Hepatic steatosis is generally a diffuse process, but focal distribution offat is quite common in the liver called focal fatty change.52 The pathogenesis is not well understood, but regional hypoxia of hepatic tissue is thought to play a role according to one theory. 53 The majority of patients have underlying disease such as diabetes, obesity, and malnutrition. Lesions are often discovered incidentally on imaging studies and characteristically show a fan-shaped or geographic pattem mainly in subcapsular areas or regions adjacent to the faIciform ligamento 54 Focal fatty change can be found as single or multiple lesions with variable sizes in a few cen-408 timeters up to 10 cm. These tumor-like lesions may be mistaken for other hepatic tumors, and liver biopsy is often required for a definitive diagnosis.53
Lipomatous Tumor
Lipomatous tumors such as hepatic angiomyolipoma or hepatic lipoma are very rare benign tumors. Patients are usually asymptomatic, and lesions are often encountered in patients with tuberous sclerosis.8 As their names imply, on the imaging studies, lipoma shows uniform fat component, whereas angiomyolipoma also contains intratumoral vessel and smooth muscle component. Atypical cases should be carefully differentiated from other hypervascular tumors including HCC, FNH, and hemangioma.55 Fine-needle aspiration is occasionally required and reveals fat cells, epithelioid smooth muscle cells, and blood vessels. 56 The prognosis is good, and surgical resection may be needed if patients have symptoms related to mass effect.57,58
lnjlammatory Pseudotumor
Inflammatory pseudotumor is an extremely rare benign hepatic tumor. It has the appearance of a malignant tumor but has a benign histology and clinical course. 59 The etiology is unclear, but underlying infectious agents are strongly suggested as the pathologic process. 60 The clinical presentation is nonspecific. Patients may have fever, malaise, weight loss, and symptoms related to a mass effect. Routine imaging procedures are not sufficient to make the diagnosis, and a biopsy is necessary to differentiate it from other tumors.61 Histologic examination reveals myofibroblasts, polyclonal plasma cell, and fibrous tissue. The course of the disease is unpredictable. In most of the reported cases, the patients underwent resection. 62 
CYSTIC TUMORS
Sim pie Cyst Pathogenesis and Pathology
Hepatic cysts are relatively common and most often discovered incidentally. Simple hepatic cysts are usually congenital. During embryogenesis, abnormal or excessive intrahepatic bile ducts develop. These ducts are obstructed or fail to connect with extrahepatic ducts and eventually form hepatic cysts. Despite their pathogenesis, communication with the biliary duct is very rare, and simple cysts usually contain clear fluid with a similar composition to serum.63 Hepatic cysts are recognized with increasing frequency as imaging modalities advance. The US prevalence is reported to be 5%. There is a strong female predominance and presentations occur most frequently in the fifth decade.64 Histologically, simple cysts are lined by simple cuboidal epithelium, identical to that of bile ducts and thin underlying rim of fibrous stroma.
Clínical Presentation and Imaging
Patients are usually asymptomatic, and solitary cysts that become symptomatic are generally larger than 5 cm. These can cause mass effects such as right upper quadrant pain. Rarely, other complicationssuch as intracystic hemorrhage and infection may develop and present a diagnostic challenge. 65 
Choledochal Cyst Pathogenesis and Pathology
Choledochal cysts are congenital bile duct anomalies. These cystic dilatations of the biliary tree can involve the extrahepatic biliary ducts, the intrahepatic biliary ducts, or both.69 Choledochal cysts are more prevalent in Asia than in the United States or other Westem countries. No strong unifying etiologic theory exists for choledochal cysts. The pathogenesis may be multifactoriaL ln many patients with choledochal cysts, an anomalous junction between the common bile duct and pancreatic duct can be demonstrated. This abnormal union allows pancreatic secretions to reflux into the common bile duct, where the pancreatic proenzymes become activated, thereby damaging and weakening the bile duct wall. Defects in epithelialization and recanalization of the developing bile ducts and congenital weakness ofthe ductal wall have also been implicated. 70 
Clinical Presentation and Imaging
The c1inicalhistory and presentation of patients with a choledochal cyst vary with the patient's age. The classic presentationsof adult patientsarejaundice, pain, and palpable @ 2005 Lippincott Williams & Wilkins mass, but some patients also present with cholangitis symptoms including fever or vague dyspeptic symptoms. 71 For diagnosing choledochal cysts, US is the modality of choice. The communication with the biliary ductal system must be demonstrated. Depending on the type of choledochal cysts, dilatation of the intrahepatic ducts and the presence of intrahepatic cysts may or may not be demonstrated. CT, MR1, and magnetic resonance cholangiopancreatography (MRCP) help to delineate the anatomy of the lesion and of the surrounding structures. These tests can also assist in defining the presence and extent of potential intrahepatic ductal involvement. lnvasive studies inc1uding percutaneous transhepatic cholangiography (PTC) or endoscopic retrograde cholangiopancreatography (ERCP) are particularly helpful in demonstrating the presence of an anomalous pancreaticobiliary junction and in delineating associated extrahepatic or intrahepatic strictures and stones.
Management
The treatment of choice for choledochal cysts is the complete excision of the cyst with a biliary-entericanastomosis to restore continuity with the gastrointestinal tract. 72 Appropriate antibiotic therapy and supportive care should be given to patients presenting with cholangitis. Laparoscopic resection of choledochal cyst and reconstruction has been reported to be technically feasible.73
Summary
Choledochal cyst is a congenital bile duct anomaly, US findings are diagnostic in many patients; however, complementary studies such as CT, MRI!MRCp, or PTC/ERCP may be helpful in the preoperative period for delineating details of the surrounding anatomy. The best treatment is complete excision with biliary-enteric reconstruction.
Echinococcal Cyst
Pathogenesis and Pathology Hydatid cysts or echinococcal cysts are still endemic in certain parts of the world and caused by the tapeworms Echinococcus granulosus or Echinococcus multilocularis. 74 Humans can become infected upon ingesting the eggs of the parasite direct1y,through contact with sheep, cats, dogs, cattle, or by contaminated water or food. 75 The liver parenchyma filters out most of the embryos, and those that are not destroyed transform into small cysts that grow over time. Depending on the condition of the parasite and the host reaction, the cyst can degenerate and may eventually collapse, leaving an area of calcification in the liver. After the initial hepatic involvement, local extension or metastatic spread to the lungs, brain, bones, or bulbous oculi may be seen in Echinococcus multilocularis infection, 76 Microscopically, hydatid cyst is composed of three layers: the outer pericyst, which corresponds to compressed hepatic tissue; the endocyst, an inner germinal layer; and the ectocyst, a translucent thin interleaved membrane. Maturation of a cyst is characterized by the development of daughter cysts in the periphery as a result of endocyst invagination, Peripheral calcifications are common in both viable and nonviable cysts. 2 
409
Clinical Presentation and Imaging
The majority of patients are asymptomatic, but some may present with abdominal pain, fever, or hepatomegaly. Anaphylactic shock may occur due to rupture of cysts into the peritoneal cavity. Helpful diagnostic features include eosinophilia, positive serologic tests, and radiologic imaging.
On US or CT, hydatid cysts appear as well-defined lesions with distinguishable walls. AIso, calcified rims, intracystic septations, and daughter cysts can be seen.77.78 MR images clearly demonstrate the pericyst, the matrix, and daughter cysts. The pericyst is seen as a hypointense rim on both Tl-and T2-weighted images because of its fibrous component and the presence of calcification. The hydatid matrix (hydatid "sand") appears hypointense on Tl-and markedly hyperintense on T2-weighted images. Daughter cysts are more hypointense than the matrix on T2-weighted images.2.74On the contrast-enhanced images, solid components of the cysts are weakly enhanced?4
Management
Surgical treatment can cure the patients ifthe entire cysts are removed. Special care should be taken not to spill the hydatid fluid during surgery because spillage of the hydatid fluid can induce anaphylactic reaction.79 Laparoscopic treatments including simple drainage, unroofing, and pericystectomy have been reported to be safe and effective.80 Medical treatment with albendazole or mebendazole only is not effective but can be used as an adjuvant therapy.
Summary
Hydatid cysts are caused by tapeworm infection, which has a worldwide distribution. Most patients are asymptomatic. Diagnosis is made by eosinophilia, positive serologic tests, and characteristic imaging features. Treatments include medical, surgical, and laparoscopic procedures.
Other Cystic Tumors
Biliary Cystadenoma
Biliary cystadenoma is an uncommon, slow-growing tumor and is considered a premalignant lesion.81 Malignant transformation to cystadenocarcinoma is not uncommon. It occurs predominantly in female patients between 30 and 50 years of age. Histologically, the tumor emerges as multilocular cyst with a single layer ofbiliary epithelium. On enhanced CT, it is a multilocular cystic lesion with typical enhancement of the cystic walls, internal septations, and mural nodules. I The MRI findings vary depending on the protein content of the fluid and the presence of an intracystic soft-tissue component. Imaging findings are similar to cystadenocarcinoma, although the polypoid projection with pedunculated excrescence is more common in cystadenocarcinoma.2 For treatment, surgical resection is mandatory if cystadenocarcinoma is suspected.82 After surgical resection, recurrence is quite common.
Von Meyenburg Complex
Bile duct hamartomas, also known as von Meyenburg complex, are relatively common benign lesions composed of disorganized proliferation of bile ductules and fibrocollagenous stroma. 83 
Caroli Disease
Caroli disease is arare, autosomal-recessive developmental disorder characterized by nonobstructive saccular dilatation of intrahepatic bile ducts, multiple intrahepatic calculi, and is associated with polycystic renal disease. 86 Clinical symptoms include recurrent attacks of fever, right upper quadrant pain, and rarely jaundice. US is the best initial imaging study because it reveals the irregular dilatation ofthe large intrahepatic ducts. On enhanced CT and MRI, the presence of tiny dots with strong enhancement within dilated intrahepatic ducts ("central dot" sign), reflecting intraluminal portal vein radicles, is very suggestive finding of Caroli disease.87 Surgical treatment may be necessary for recurrent or refractory cholangitis. Broad-spectrum antibiotic coverage is indicated in cases of cholangitis.
Peliosis Hepatica
Peliosis hepatis is arare benign lesion that is characterized by the presence of diffuse blood-filled cystic spaces. It can occur in the liver, spleen, bone marrow, and lungs.88 It has been reported to associate with long-term treatment of steroid, estrogen, tamoxifen, immunoglobulin, malignancy (hepatocellular carcinoma and adenoma), hematologic disease (Hodgkin disease, multiple myeloma), renal transplantation, and infections (tuberculosis, AIDS). Radiologic imaging findings are cystic lesions with variable sizes. Sometimes, very smalllesions are detected as noncystic or diffuse hepatic lesions.88.89Treatment should include withdrawal of the possible causative agents and specific treatment such as antibiotics in patients with either primary or secondary infections.
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